Senate debate over kratom regulation stalls after lengthy floor exchange

Senators on the Missouri Senate floor spent much of the session debating a substitute for Senate Bill 16‑05, an effort to regulate kratom products and the synthetic compound commonly called 7‑OH. The sponsor, the senator from Saint Francis, framed the measure as “guardrails” to protect children and curtail adulterated products while leaving legal, unadulterated kratom on the market.

Senator from Saint Francis said the substitute sets a testing threshold and labeling regime aimed at distinguishing ordinary kratom products from enhanced or adulterated forms: “If you get above 1,000 parts per million, then you’re in the no‑fly zone basically,” he said, explaining the 1,000 parts‑per‑million dry‑weight threshold he and law enforcement recommended. The substitute would require ingredient lists, warning statements (including a disclosure that the Food and Drug Administration has not evaluated the products), and an age‑21 purchase restriction with ID checks at retail.

Other senators pressed the sponsor on how the threshold would work in practice and on broader policy choices. The senator from Boone asked whether the bill treats kratom and enhanced 7‑OH products differently; the sponsor said the distinction was intentional, noting that 7‑OH occurs naturally in trace amounts in kratom but becomes dangerous when concentrated or synthesized. Several senators urged adding stronger restrictions on marketing and sales locations to reduce youth exposure; one colleague proposed restricting sales to establishments that limit entry to ages 21 and older.

A competing amendment would have banned all kratom sales statewide. Advocates of a full ban warned that leaving one product on the market while banning another could push users toward the remaining product, potentially worsening addiction problems. The sponsor said he had not carried the votes to ban the whole market and sought to take a narrower approach focused on the most dangerous adulterated products.

The floor exchange involved repeated offers to compromise: numerous senators said they supported age gating, tighter packaging and labeling restrictions, and clearer enforcement language; they disagreed on whether removing adulterated 7‑OH entirely was the right immediate step. Senator from Clay highlighted public‑health concerns and cited federal and state advisories, saying 7‑OH has a high potential for abuse and can cause overdose that responds to Narcan.

After extended questioning, several amendment offers and discussion of enforcement and penalty levels, the sponsor asked to lay the substitute over for further work. The Senate placed SB 16‑05 on the informal calendar rather than taking final action during this session day.

What remains: the substitute contains a 1,000 ppm threshold for concentrated 7‑OH, labeling and disclosure requirements, an age‑21 sales restriction with ID checks, and potential infraction penalties for violations; the most contentious unresolved items are whether to ban adulterated products outright and how far to restrict retail venues and penalties. The bill will return to the floor for additional amendment work and a future vote.